Skip to main content
Top
Published in: Diabetologia 12/2010

01-12-2010 | Short Communication

Low birthweight and premature birth are both associated with type 2 diabetes in a random sample of middle-aged Danes

Authors: K. Pilgaard, K. Færch, B. Carstensen, P. Poulsen, C. Pisinger, O. Pedersen, D. R. Witte, T. Hansen, T. Jørgensen, A. Vaag

Published in: Diabetologia | Issue 12/2010

Login to get access

Abstract

Aims/hypothesis

We studied the associations of size at birth and prematurity with type 2 diabetes, insulin sensitivity and beta cell function in the Danish population-based Inter99 study (ClinicalTrials.gov NCT00289237).

Methods

Information about size at birth and prematurity was identified from original midwife records in 4,744 middle-aged Danes. Type 2 diabetes status, insulin sensitivity (Matsuda index) and beta cell function (disposition index) were assessed using a 75 g oral glucose tolerance test. Participants born prematurely were compared with a group of at-term participants born small for gestational age.

Results

An increase in birthweight of 1 kg was associated with a 51% (OR 0.49, 95% CI 0.35–0.69) reduced risk of type 2 diabetes. Ponderal index, reflecting thinness at birth, was associated with type 2 diabetes to the same extent as birthweight. The prevalence of type 2 diabetes was increased to a similar degree in participants born prematurely and participants born small for gestational age, although the former had a higher ponderal index at birth. In addition, birthweight z-scores, reflecting fetal growth rate, were unrelated to the risk of type 2 diabetes and to other measures of glucose regulation in participants born prematurely. While low birthweight was inversely associated with insulin sensitivity and beta cell function, prematurity was associated solely with decreased insulin sensitivity.

Conclusions/interpretation

While the association between birthweight and risk of type 2 diabetes is mediated via combined effects on beta cell function and insulin sensitivity, prematurity seems to influence risk of type 2 diabetes via attenuated insulin sensitivity only and independently of fetal growth rates.
Literature
1.
go back to reference Hales CN, Barker DJ, Clark PM et al (1991) Fetal and infant growth and impaired glucose tolerance at age 64. BMJ, Br Med J 303:1019–1022CrossRef Hales CN, Barker DJ, Clark PM et al (1991) Fetal and infant growth and impaired glucose tolerance at age 64. BMJ, Br Med J 303:1019–1022CrossRef
2.
go back to reference Lithell HO, McKeigue PM, Berglund L, Mohsen R, Lithell UB, Leon DA (1996) Relation of size at birth to non-insulin dependent diabetes and insulin concentrations in men aged 50–60 years. BMJ (Clinical research ed) 312:406–410 Lithell HO, McKeigue PM, Berglund L, Mohsen R, Lithell UB, Leon DA (1996) Relation of size at birth to non-insulin dependent diabetes and insulin concentrations in men aged 50–60 years. BMJ (Clinical research ed) 312:406–410
3.
go back to reference Phillips DI, Barker DJ, Hales CN, Hirst S, Osmond C (1994) Thinness at birth and insulin resistance in adult life. Diabetologia 37:150–154CrossRefPubMed Phillips DI, Barker DJ, Hales CN, Hirst S, Osmond C (1994) Thinness at birth and insulin resistance in adult life. Diabetologia 37:150–154CrossRefPubMed
4.
go back to reference Hofman PL, Regan F, Jackson WE et al (2004) Premature birth and later insulin resistance. N Engl J Med 351:2179–2186CrossRefPubMed Hofman PL, Regan F, Jackson WE et al (2004) Premature birth and later insulin resistance. N Engl J Med 351:2179–2186CrossRefPubMed
5.
go back to reference Kaijser M, Bonamy AK, Akre O et al (2009) Perinatal risk factors for diabetes in later life. Diabetes 58:523–526CrossRefPubMed Kaijser M, Bonamy AK, Akre O et al (2009) Perinatal risk factors for diabetes in later life. Diabetes 58:523–526CrossRefPubMed
6.
go back to reference Jørgensen T, Borch-Johnsen K, Thomsen TF, Ibsen H, Glümer C, Pisinger C (2003) A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99 (1). Eur J Cardiovasc Prev Rehab 10:377–386CrossRef Jørgensen T, Borch-Johnsen K, Thomsen TF, Ibsen H, Glümer C, Pisinger C (2003) A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99 (1). Eur J Cardiovasc Prev Rehab 10:377–386CrossRef
7.
go back to reference Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539–553CrossRefPubMed Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539–553CrossRefPubMed
8.
go back to reference Pilgaard K, Faerch P, Poulsen, C et al. (2010) Impact of size at birth and prematurity on adult anthropometry in 4744 middle-aged Danes—the Inter99 Study. Journal of Developmental Origins of Health and Disease doi:10.1017/S2040174410000413 Pilgaard K, Faerch P, Poulsen, C et al. (2010) Impact of size at birth and prematurity on adult anthropometry in 4744 middle-aged Danes—the Inter99 Study. Journal of Developmental Origins of Health and Disease doi:10.​1017/​S204017441000041​3
9.
go back to reference Niklasson A, Ericson A, Fryer JG, Karlberg J, Lawrence C, Karlberg P (1991) An update of the Swedish reference standards for weight, length and head circumference at birth for given gestational age (1977–1981). Acta Paediatr Scand 80:756–762CrossRefPubMed Niklasson A, Ericson A, Fryer JG, Karlberg J, Lawrence C, Karlberg P (1991) An update of the Swedish reference standards for weight, length and head circumference at birth for given gestational age (1977–1981). Acta Paediatr Scand 80:756–762CrossRefPubMed
10.
go back to reference Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419CrossRefPubMed Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419CrossRefPubMed
11.
go back to reference Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diab Care 22:1462–1470CrossRef Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diab Care 22:1462–1470CrossRef
12.
go back to reference McCance DR, Pettitt DJ, Hanson RL, Jacobsson LT, Knowler WC, Bennett PH (1994) Birth weight and non-insulin dependent diabetes: thrifty genotype, thrifty phenotype, or surviving small baby genotype? BMJ (Clinical research ed) 308:942–945 McCance DR, Pettitt DJ, Hanson RL, Jacobsson LT, Knowler WC, Bennett PH (1994) Birth weight and non-insulin dependent diabetes: thrifty genotype, thrifty phenotype, or surviving small baby genotype? BMJ (Clinical research ed) 308:942–945
13.
go back to reference Cook JT, Levy JC, Page RC, Shaw JA, Hattersley AT, Turner RC (1993) Association of low birth weight with beta cell function in the adult first degree relatives of non-insulin dependent diabetic subjects. BMJ 306:302–306CrossRefPubMed Cook JT, Levy JC, Page RC, Shaw JA, Hattersley AT, Turner RC (1993) Association of low birth weight with beta cell function in the adult first degree relatives of non-insulin dependent diabetic subjects. BMJ 306:302–306CrossRefPubMed
Metadata
Title
Low birthweight and premature birth are both associated with type 2 diabetes in a random sample of middle-aged Danes
Authors
K. Pilgaard
K. Færch
B. Carstensen
P. Poulsen
C. Pisinger
O. Pedersen
D. R. Witte
T. Hansen
T. Jørgensen
A. Vaag
Publication date
01-12-2010
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 12/2010
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-010-1917-3

Other articles of this Issue 12/2010

Diabetologia 12/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.